Specific deletion of CDC42 in pancreatic cells attenuates glucose-induced insulin expression and secretion in mice

Xiang-Qin He,Ning Wang,Juan-Juan Zhao,Dan Wang,Cai-Ji Wang,Lin Xie,Huai-Yu Zheng,Shui-Zhen Shi,Jing He,Jiliang Zhou,Hong-Bo Xin,Ke-Yu Deng
DOI: https://doi.org/10.1016/j.mce.2020.111004
IF: 4.369
2020-01-01
Molecular and Cellular Endocrinology
Abstract:Insulin is a key hormone for maintaining glucose homeostasis in organisms. In general, deficiency of insulin synthesis and secretion results in type I diabetes, whereas insulin resistance leads to type 2 diabetes. Cell division cycle 42 (CDC42), a member of Rho GTPases family, has been shown as an essential regulator in the second phase of glucose-induced insulin secretion in pancreatic islets beta cells in vitro. However, the effect of CDC42 on insulin expression has not been explored. Here we reported that the glucose-induced insulin expression and secretion were significantly inhibited in mice lacking CDC42 gene in pancreatic 1 cells (Rip-CDC42cKO) in vivo and in vitro. Deletion of CDC42 gene in pancreatic 1 cells did not affect survival or reproduction in mice. However, the Rip-CDC42cKO mice showed the systemic glucose intolerance and the decrease of glucose-induced insulin secretion without apparent alterations of peripheral tissues insulin sensitivity and the morphology of islets. Furthermore, we demonstrated that deletion of CDC42 gene in pancreatic 1 cells significantly attenuated the insulin expression through inhibiting the ERK1/2-NeuroD1 signaling pathway. Taken together, our study presents novel evidence that CDC42 is an important modulator in glucose-induced insulin expression as well as insulin secretion in pancreatic beta cells.
What problem does this paper attempt to address?